trial · primary record
VRN110755
EGFR-Mutant Non-Small Cell Lung Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 315 |
| Primary completion | 2029-10-01 |
| Primary endpoint | Estimate of Maximum Tolerated Dose (MTD) of VRN110755 |
| Registry ID | NCT07699328 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:33.198Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07699328
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.